What is the best way to treat facial hemangioma?

Facial hemangioma is a relatively common skin disease in today's society. It is usually caused by abnormal blood vessels and is usually discovered shortly after birth. Although some capillary hemangiomas may disappear with age, hemangiomas usually grow faster than the growth and development of the child. If not treated in the early stages, it will have a great impact on the patient's appearance, so early treatment is necessary. So what is the best way to treat facial hemangiomas?

Facial hemangiomas are common in clinical practice. They are caused by abnormal proliferation of blood vessels and are of the nature of vascular malformations or hamartomas. Most of them are discovered shortly after birth. As the child grows and develops, the hemangioma enlarges. Although some capillary hemangiomas can shrink or disappear naturally, hemangiomas generally grow faster than the growth and development of the child. If not treated in time, it will affect the appearance and function of facial tissues. Facial hemangiomas are divided into four types according to their pathological tissue structure and clinical characteristics: capillary hemangioma, cavernous hemangioma, mixed hemangioma, and racemose hemangioma. The first two types are the most common.

Most of them are present at birth, initially appearing in the shape of a vascular nevus, or in the form of flakes, which then grow larger as the baby grows. They can occur on any part of the face, and sometimes are widespread, occupying half of the face. They are red, purple, or dark red, flat or slightly protruding from the skin, soft to the touch, and fade when pressed. Hemangiomas grow faster in children under 1 year old and slower in children over 1 year old. A few may stop growing or even shrink and disappear. Hemangioma lesions are located in the dermis of the skin and are composed of dense and tiny capillaries formed by the proliferation of vascular endothelial cells.

The second-generation new photosensitizer (Hemoporfin) is injected into the body through the intravenous route. Immediately after intravenous injection, Hemoporfin forms a peak concentration in the blood and is rapidly absorbed by vascular endothelial cells, while the epidermal cells absorb very little. Therefore, the distribution of the photosensitizer forms an obvious concentration difference between the vascular endothelial cells and the epidermal cells. At this time, light of a specific wavelength that can penetrate the surface and be selectively absorbed by vascular endothelial cells is irradiated, causing Hemoporfin to produce phototoxic substances such as singlet oxygen.

The above is what the editor introduced to you about how to treat facial hemangioma effectively. I believe it will be of some help to you. The editor recommends that patients with facial hemangioma can go to a regular hospital for examination as soon as possible and receive treatment from a doctor based on their own situation. Do not take medication blindly, especially cosmetics. In addition, you must develop good living habits and maintain a good attitude.